BOLD vs BXP · P/E 0.1, $24.6M cap vs rev $3.48B
Boundless Bio, Inc. Common Stock (BOLD) versus Boston Properties Inc (BXP) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
Boston Properties Inc (BXP) is a reit - office company listed on US.
BOLD does not have a complete income-statement cache yet.
Latest reported BXP revenue for 2025-12-31 was $3.48B. Net income was $276.8M. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BXP currently screens at market cap $12.12B.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. BXP currently screens at market cap $12.12B.
Not investment advice. Open the BOLD and BXP stock pages for the full models.
Not investment advice.